Ascend Wellness Holdings, Inc.
Ascend Wellness Holdings, Inc. (AAWH) Financial Performance & Income Statement Overview
Analyze Ascend Wellness Holdings, Inc. (AAWH) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Ascend Wellness Holdings, Inc. (AAWH) Income Statement & Financial Overview
Review Ascend Wellness Holdings, Inc. AAWH income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $128.00M | $136.006M | $141.65M | $141.54M |
| Cost of Revenue | $88.44M | $89.14M | $97.92M | $99.96M |
| Gross Profit | $39.56M | $46.87M | $43.73M | $41.57M |
| Gross Profit Ratio | $0.31 | $0.34 | $0.31 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $37.08M | $31.82M | $46.15M | $34.52M |
| Operating Expenses | $37.08M | $40.77M | $46.15M | $43.09M |
| Total Costs & Expenses | $125.51M | $138.62M | $144.06M | $143.06M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$11.19M | $11.71M | $11.006M | $8.54M |
| Depreciation & Amortization | $0.00 | $17.98M | $17.11M | $16.33M |
| EBITDA | $2.49M | $23.69M | $9.63M | $15.19M |
| EBITDA Ratio | $0.02 | $0.17 | $0.07 | $0.11 |
| Operating Income | $2.49M | $6.10M | -$2.42M | -$1.52M |
| Operating Income Ratio | $0.02 | $0.04 | -$0.02 | -$0.01 |
| Other Income/Expenses (Net) | -$10.71M | -$12.10M | -$16.07M | -$8.16M |
| Income Before Tax | -$8.23M | -$6.002M | -$18.49M | -$9.68M |
| Income Before Tax Ratio | -$0.06 | -$0.04 | -$0.13 | -$0.07 |
| Income Tax Expense | -$11.03M | $10.79M | $9.77M | $12.11M |
| Net Income | -$19.26M | -$16.79M | -$28.26M | -$21.78M |
| Net Income Ratio | -$0.15 | -$0.12 | -$0.20 | -$0.15 |
| EPS | -$0.09 | -$0.08 | -$0.13 | -$0.10 |
| Diluted EPS | -$0.09 | -$0.08 | -$0.13 | -$0.10 |
| Weighted Avg Shares Outstanding | $205.00M | $212.43M | $214.29M | $213.16M |
| Weighted Avg Shares Outstanding (Diluted) | $205.00M | $212.43M | $214.29M | $213.16M |
Financial performance has remained strong, with revenue growing from $141.54M in Q2 2024 to $128.00M in Q1 2025. Gross profit continued to perform well, with margins at 31% in the latest quarter. Operating income reached $2.49M in Q1 2025, holding a steady 2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $2.49M. Net income dropped to -$19.26M, keeping EPS at -$0.09. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan